Kieger Sustainable Healthcare Fund Class B EUR Accumulating

Reference Data

ISIN LU2488092649
Valor Number 119403766
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class B EUR Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). No guarantee can be given that the investment objective will be achieved.
Peculiarities

Fund Prices

Current Price * 114.03 EUR 21.11.2024
Previous Price * 113.10 EUR 20.11.2024
52 Week High * 119.70 EUR 30.08.2024
52 Week Low * 97.51 EUR 28.11.2023
NAV * 114.03 EUR 21.11.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 296,893,053
Unit/Share Assets *** 122,036
Trading Information SIX

Performance

YTD Performance +10.26% 29.12.2023
21.11.2024
YTD Performance (in CHF) +10.29% 29.12.2023
21.11.2024
1 month -2.71% 21.10.2024
21.11.2024
3 months -2.41% 21.08.2024
21.11.2024
6 months -0.37% 22.05.2024
21.11.2024
1 year +16.14% 21.11.2023
21.11.2024
2 years +14.03% 06.07.2023
21.11.2024
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 5.55%
Merck & Co Inc 5.32%
Novo Nordisk AS Class B 4.83%
UnitedHealth Group Inc 4.68%
Thermo Fisher Scientific Inc 4.52%
Abbott Laboratories 4.32%
AstraZeneca PLC 4.17%
GSK PLC 4.16%
Stryker Corp 4.02%
Boston Scientific Corp 3.85%
Last data update 30.04.2024

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges ***
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 *** Sustainable Investment
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)